Lotemax

Lotemax (loteprednol etabonate) is a new topical antiinflammatory for ophthalmic use.

Treatment with Lotemax 0.5% eye drops is indicated for postoperative inflammation following ocular surgery.

One to two drops are used four times daily beginning 24 hours after surgery, continuing for up to two weeks throughout the post-operative period.

View Lotemax drug record

Further information: Bausch & Lomb

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Last chance to register for the next Respiratory and Allergy Learning Series event

Last chance to register for the next Respiratory and Allergy Learning Series event

Join Dr Steve Holmes, who will be chairing the MIMS...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Accrete D3.
Use our constantly updated...

Don't prescribe antibiotics for non-bullous impetigo, draft NICE guidance advises

Don't prescribe antibiotics for non-bullous impetigo, draft NICE guidance advises

Topical antiseptics are preferable to antibiotics for...

Contraceptives

Contraceptives

Hormone doses and costs of hormonal contraceptives.